The US Secretary of Health and Human Services, Michael Leavitt, has criticized Indonesia's government for its refusal to share avian influenza samples. The US official's position mirrors that of the World Health Organization (Marketletters passim). However, the fact that most of the world's major drug companies are headquartered in the USA and, according to Indonesia's Health Minister, Siti Fadilah Supari, have most to gain commercially from the development of a vaccine against a pandemic flu outbreak, makes it likely that the call will not be well received.
Mr Leavitt told the Associated Press, while on a tour of Indonesia, Singapore and Vietnam, that "if Indonesia decides not to be a part of the world community and the international mainstream on this for a time, that would be regrettable."
In March, the US Embassy in Jakarta, Indonesia, was forced to deny conspiracy theories circulating in the capital that H5N1 samples were being collected by the US military for the development of biological weapons (Marketletter March 24).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze